US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Release time：2024-05-22 02:10:11 Source：World Web news portal
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
- Previous：David Ortiz is humbled by being honored in New York again; this time for post
- Next：Pregnancy app used by the NHS accused of 'imposing gender ideology'
Related articles
- Who is Jacob Zuma, the former South African president disqualified from next week's election?
- 16 black bear cubs rescued in Lao capital
- The glare of car headlights could be a risk for heart conditions... As ever
- Netflix's '3 Body Problem' promotes Chinese culture despite controversy
- Nadal returns to Roland Garros to practice amid doubts over fitness and form
- QUENTIN LETTS: We can guess who plenty of Labour MPs would cheer in an Israel
- Chinese military spokesperson answers media questions during annual legislative session
- Canadian gov't announces plan to solve national housing crisis
- Revealed: Brit tourist, 19, subjected to sex attack in Majorca 'was gang
- QUENTIN LETTS: We can guess who plenty of Labour MPs would cheer in an Israel
- Harris accepts debate invite to face off with Trump's VP pick, which may come at convention
- GENERAL JACOB NAGEL: Why Israel's failure to strike back at Iran could lead to NUCLEAR WAR
- James Martin shares health update as he returns to TV following cancer battle
- HKSAR LegCo unanimously passes milestone bill to better safeguard national security
- Devout Christian doctor, 68, who punched dementia
- The marathon task of trying America's most famous man: Trump 'smirked' as he became the first ex
- 14 killed, 37 injured in passenger bus crash in north China
- Israel accused of deadly strike on Iranian consulate in Syria
- Inquiry slams UK authorities for failures that killed thousands in infected blood scandal
- China denounces EU's pretext for anti
Random recommendation
- Copyright © 2024 Powered by US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition ,World Web news portal sitemap